<DOC>
	<DOCNO>NCT01898910</DOCNO>
	<brief_summary>The investigator conduct prospective , double-blind , randomize study ass comparative safety efficacy two different strategy , PVI plus Renal Denervation ( RD ) versus PVI plus GP ablation , patient atrial fibrillation . Results assess follow-up least 1 year use implant monitoring device ( IMD ) .</brief_summary>
	<brief_title>Ganglionated Plexi Ablation v Renal Denervation Patients Undergoing Pulmonary Vein Isolation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Symptomatic drugrefractory AF ( history failure ≥ 2 class I III antiarrhythmic drug ) patient refer catheter ablation AF PAF ≥1 monthly episode PersAF patient already undergone ≥3 electrical cardioversions . PAF define episode last less 7 day spontaneous termination . PersAF define last 7 day terminate pharmacologically electrical cardioversion . History significant hypertension ( define SBP ≥ 160 mmHg and/or DBP ≥ 100 mmHg ) , receive treatment least one antihypertensive medication A glomerular filtration rate ≥45 mL/min/1⋅73 m2 , modification diet use renal disease formula Previous atrial fibrillation ablation Type 1 diabetes mellitus Structural heart disease Secondary cause atrial hypertension Severe renal artery stenosis renal artery abnormalities Previous operation renal artery Pregnancy Previous heart , kidney , liver , lung transplantation Unwillingness participant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>